Topical interferon alpha 2b may increase risk of corneal melt in predisposed patients

• Posted on: Sep 21 2020
• By: Saratoga Opthalmology
• Leave a response

This case report describes corneal melt in a patient treated with topical interferon (INF) alpha 2b for conjunctival intraepithelial neoplasia (CIN) and carcinoma in situ of the cornea.
Source: AAO

Posted in: Uncategorized